Bio-Techne Corp (TECH)
71.28
+0.23
(+0.32%)
USD |
NASDAQ |
Nov 22, 16:00
71.28
0.00 (0.00%)
After-Hours: 20:00
Bio-Techne Debt to Equity Ratio: 0.1403 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.1403 |
| June 30, 2024 | 0.1542 |
| March 31, 2024 | 0.1931 |
| December 31, 2023 | 0.2276 |
| September 30, 2023 | 0.2202 |
| June 30, 2023 | 0.178 |
| March 31, 2023 | 0.1958 |
| December 31, 2022 | 0.1095 |
| September 30, 2022 | 0.1511 |
| June 30, 2022 | 0.1504 |
| March 31, 2022 | 0.1511 |
| December 31, 2021 | 0.1657 |
| September 30, 2021 | 0.1831 |
| June 30, 2021 | 0.2184 |
| March 31, 2021 | 0.1399 |
| December 31, 2020 | 0.1521 |
| September 30, 2020 | 0.2249 |
| June 30, 2020 | 0.2583 |
| March 31, 2020 | 0.3251 |
| December 31, 2019 | 0.2894 |
| September 30, 2019 | 0.4139 |
| June 30, 2019 | 0.4334 |
| March 31, 2019 | 0.4556 |
| December 31, 2018 | 0.4974 |
| September 30, 2018 | 0.5061 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.3142 |
| March 31, 2018 | 0.3709 |
| December 31, 2017 | 0.3633 |
| September 30, 2017 | 0.3516 |
| June 30, 2017 | 0.362 |
| March 31, 2017 | 0.3945 |
| December 31, 2016 | 0.3899 |
| September 30, 2016 | 0.3878 |
| June 30, 2016 | 0.1083 |
| March 31, 2016 | 0.1895 |
| December 31, 2015 | 0.1945 |
| September 30, 2015 | 0.2008 |
| June 30, 2015 | 0.0909 |
| March 31, 2015 | 0.189 |
| December 31, 2014 | 0.1913 |
| September 30, 2014 | 0.1575 |
| June 30, 2014 | 0.0163 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.1095
Minimum
Dec 2022
0.3251
Maximum
Mar 2020
0.1914
Average
0.1805
Median
Debt to Equity Ratio Benchmarks
| Bio-Rad Laboratories Inc | 0.1604 |
| Boston Scientific Corp | 0.5254 |
| ResMed Inc | 0.1304 |
| Zimmer Biomet Holdings Inc | 0.5311 |
| AIM ImmunoTech Inc | 0.9382 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 2.736B |
| Total Liabilities (Quarterly) | 597.37M |
| Shareholders Equity (Quarterly) | 2.139B |
| Current Ratio | 4.563 |
| Net Debt Paydown Yield | 0.08% |